×
About 1,790 results

ALLMedicine™ Histoplasmosis Center

Research & Reviews  572 results

Mycobacterial and Opportunistic Infections in HIV-Negative Thai and Taiwanese Patients Associated With Autoantibodies to Interferon-gamma
https://clinicaltrials.gov/ct2/show/NCT00814827

Jun 24th, 2022 - The acquisition of opportunistic infections has been causally linked to innate and acquired immunodeficiencies. We have recently identified a population of Asian women with autoantibodies to interferon gamma (IFN?), all of whom were diagnosed by v...

Pulmonary Blastomycosis Imaging
https://emedicine.medscape.com/article/354067-overview

May 20th, 2022 - Practice Essentials Blastomyces dermatitidis is a thermally dimorphic fungus that causes the systemic pyogranulomatous disease termed blastomycosis. This pathogen is endemic to North America, particularly in the states bordering the Mississippi an...

Pulmonary Blastomycosis Imaging
http://emedicine.medscape.com/article/354067-overview

May 20th, 2022 - Practice Essentials Blastomyces dermatitidis is a thermally dimorphic fungus that causes the systemic pyogranulomatous disease termed blastomycosis. This pathogen is endemic to North America, particularly in the states bordering the Mississippi an...

Pulmonary Blastomycosis Imaging
https://emedicine.medscape.com/article/354067-print

May 20th, 2022 - Blastomyces dermatitidis is a thermally dimorphic fungus that causes the systemic pyogranulomatous disease termed blastomycosis. This pathogen is endemic to North America, particularly in the states bordering the Mississippi and Ohio rivers, the G...

Endemic Mycoses Treatment With SUBA-itraconazole vs Itraconazole
https://clinicaltrials.gov/ct2/show/NCT03572049

May 16th, 2022 - This is a prospective, multi-center, randomized, open-label parallel arm study involving patients with proven or probable invasive endemic fungal infection to ascertain the pharmacokinetics, safety, efficacy, and tolerability of oral SUBA-itracona...

see more →

Drugs  52 results see all →

Clinicaltrials.gov  29 results

Mycobacterial and Opportunistic Infections in HIV-Negative Thai and Taiwanese Patients Associated With Autoantibodies to Interferon-gamma
https://clinicaltrials.gov/ct2/show/NCT00814827

Jun 24th, 2022 - The acquisition of opportunistic infections has been causally linked to innate and acquired immunodeficiencies. We have recently identified a population of Asian women with autoantibodies to interferon gamma (IFN?), all of whom were diagnosed by v...

Endemic Mycoses Treatment With SUBA-itraconazole vs Itraconazole
https://clinicaltrials.gov/ct2/show/NCT03572049

May 16th, 2022 - This is a prospective, multi-center, randomized, open-label parallel arm study involving patients with proven or probable invasive endemic fungal infection to ascertain the pharmacokinetics, safety, efficacy, and tolerability of oral SUBA-itracona...

Study of Entry and Continuation in Care for People Living With HIV in French Guiana
https://clinicaltrials.gov/ct2/show/NCT05354934

May 2nd, 2022 - French Guyana is the French territory most affected by the HIV epidemic, with a prevalence estimated at between 1.13 and 1.18% of the adult population aged 15 to 49, and the incidence remains high at 0.90 per 1,000 people in 2018(1,2). Although Fr...

Making an Early Diagnosis of Talaromycosis Using a Novel Antigen Test
https://clinicaltrials.gov/ct2/show/NCT04033120

Mar 4th, 2022 - This study aims to determine the diagnostic and prognostic values and the clinical impact of Talaromyces marneffei antigenemia (TmAg) in patients with advanced HIV disease using a novel enzyme immunoassay (EIA) detecting Tm-specific cell wall mann...

A Study of Itraconazole in the Treatment and Prevention of Histoplasmosis, a Fungal Infection, in Patients With AIDS
https://clinicaltrials.gov/ct2/show/NCT00000975

Nov 4th, 2021 - Histoplasmosis is a serious opportunistic infection in patients with AIDS. Although the clinical response to amphotericin B treatment in the AIDS patients is generally good, administration difficulties and toxicity detract from its usefulness. Ora...

see more →

News  60 results

72-year-old man • fever • new-onset urinary frequency • altered mental state • Dx?
https://www.mdedge.com/familymedicine/article/248466/infectious-diseases
MDedge Family Medicine; Tenzin Tsewang, MD, James Mayberry, MD et. al.

Nov 9th, 2021 - THE CASE A 72-year-old man was admitted to our Dallas hospital with a 4-day history of fevers and new-onset urinary frequency. He did not report any joint pain, sick contacts, or recent travel or recall any skin findings (rashes, insect bites).

Acyclovir-Resistant Cutaneous Herpes Simplex Virus in DOCK8 Deficiency
https://www.mdedge.com/dermatology/article/247305/pediatrics/acyclovir-resistant-cutaneous-herpes-simplex-virus-dock8
Christina R. Hopkins, MD, Nicholas Lowe, MD et. al.

Oct 12th, 2021 - Dedicator of cytokinesis 8 (DOCK8 ) deficiency is the major cause of autosomal-recessive hyper-IgEsyndrome. 1 Characteristic clinical features including eosinophilia, eczema, and recurrent Staphylococcus aureus cutaneous and respiratory tract infe.

Breast Cancer Management: Monitoring Patients for ILD
https://www.onclive.com/view/breast-cancer-management-monitoring-patients-for-ild

Sep 8th, 2021 - Mark D. Pegram, MD: Interstitial lung disease [ILD] is a diagnosis of exclusion. It’s seen with numerous drugs that we use in breast cancer, such as CDK4/6 inhibitors, everolimus, and trastuzumab deruxtecan. So we are constantly screening for this...

Ulcerated and Verrucous Plaque on the Chest
https://www.mdedge.com/dermatology/article/244365/infectious-diseases/ulcerated-and-verrucous-plaque-chest
Mahdieh Fazel Jedlowski, MD, PharmD, Patrick Michael Jedlowski, MD

Aug 17th, 2021 - The Diagnosis: Disseminated Coccidioidomycosis A6-mm punch biopsy was performed at the periphery of the ulcerated cutaneous lesion on the chest revealing extensive spherules. Serum antibody immunodiffusion for histoplasmosis and blastomycoses both.

Key Considerations in the Management of Stage 3 NSCLC
https://www.onclive.com/view/key-considerations-in-the-management-of-stage-3-nsclc

Apr 2nd, 2021 - Transcript: Mark Kris, MD: I’d also like to say a few words about this group of patients with stage 3 lung cancer. The focus, today, is going to be on people who are inoperable and unresectable. There’s no question that those folks are best ma...

see more →

Patient Education  3 results see all →